Related references
Note: Only part of the references are listed.Tuning T cell receptor sensitivity through catch bond engineering
Xiang Zhao et al.
SCIENCE (2022)
Preclinical evaluation of an affinity-enhanced MAGE-A4-specific T-cell receptor for adoptive T-cell therapy
Joseph P. Sanderson et al.
ONCOIMMUNOLOGY (2020)
CRISPR-engineered T cells in patients with refractory cancer
Edward A. Stadtmauer et al.
SCIENCE (2020)
Computational stabilization of T cell receptors allows pairing with antibodies to form bispecifics
Karen Froning et al.
NATURE COMMUNICATIONS (2020)
Massively parallel interrogation and mining of natively paired human TCRαβ repertoires
Matthew J. Spindler et al.
NATURE BIOTECHNOLOGY (2020)
Human cytomegalovirus-specific T-cell receptor engineered for high affinity and soluble expression using mammalian cell display
Ellen K. Wagner et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
T cell receptor gene therapy targeting WT1 prevents acute myeloid leukemia relapse post-transplant
Aude G. Chapuis et al.
NATURE MEDICINE (2019)
Orthotopic replacement of T-cell receptor α- and β-chains with preservation of near-physiological T-cell function
Kilian Schober et al.
NATURE BIOMEDICAL ENGINEERING (2019)
TCR Fingerprinting and Off-Target Peptide Identification
Armen R. Karapetyan et al.
FRONTIERS IN IMMUNOLOGY (2019)
Chronic TCR-MHC (self)-interactions limit the functional potential of TCR affinity-increased CD8 T lymphocytes
Minh Ngoc Duong et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Affinity-enhanced T-cell receptors for adoptive T-cell therapy targeting MAGE-A10: strategy for selection of an optimal candidate
Ellen C. Border et al.
ONCOIMMUNOLOGY (2019)
Transient expression of human antibodies in mammalian cells
Rodrigo Vazquez-Lombardi et al.
NATURE PROTOCOLS (2018)
Antigen Identification for Orphan T Cell Receptors Expressed on Tumor-Infiltrating Lymphocytes
Marvin H. Gee et al.
CELL (2018)
Peptide-MHC Class I Tetramers Can Fail To Detect Relevant Functional T Cell Clonotypes and Underestimate Antigen-Reactive T Cell Populations
Cristina Rius et al.
JOURNAL OF IMMUNOLOGY (2018)
High-throughput antibody engineering in mammalian cells by CRISPR/Cas9-mediated homology-directed mutagenesis
Derek M. Mason et al.
NUCLEIC ACIDS RESEARCH (2018)
Isolation of a Structural Mechanism for Uncoupling T Cell Receptor Signaling from Peptide-MHC Binding
Leah V. Sibener et al.
CELL (2018)
Reprogramming human T cell function and specificity with non-viral genome targeting
Theodore L. Roth et al.
NATURE (2018)
Generation of higher affinity T cell receptors by antigen-driven differentiation of progenitor T cells in vitro
Thomas M. Schmitt et al.
NATURE BIOTECHNOLOGY (2017)
Clinical responses to adoptive T-cell transfer can be modeled in an autologous immune-humanized mouse model
Henrik Jespersen et al.
NATURE COMMUNICATIONS (2017)
Fine-Tuning of Optimal TCR Signaling in Tumor-Redirected CD8 T Cells by Distinct TCR Affinity-Mediated Mechanisms
Danilo Presotto et al.
FRONTIERS IN IMMUNOLOGY (2017)
ggseqlogo: a versatile R package for drawing sequence logos
Omar Wagih
BIOINFORMATICS (2017)
Plasmid-based one-pot saturation mutagenesis
Emily E. Wrenbeck et al.
NATURE METHODS (2016)
Targeting of cancer neoantigens with donor-derived T cell receptor repertoires
Erlend Stronen et al.
SCIENCE (2016)
T cell receptor binding affinity governs the functional profile of cancer-specific CD8+ T cells
M. P. Tan et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2015)
NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myeloma
Aaron P. Rapoport et al.
NATURE MEDICINE (2015)
Efficient modification of CCR5 in primary human hematopoietic cells using a megaTAL nuclease and AAV donor template
Blythe D. Sather et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Identifying Individual T Cell Receptors of Optimal Avidity for Tumor Antigens
Michael Hebeisen et al.
FRONTIERS IN IMMUNOLOGY (2015)
A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1-Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response
Paul F. Robbins et al.
CLINICAL CANCER RESEARCH (2015)
Full-length RNA-seq from single cells using Smart-seq2
Simone Picelli et al.
NATURE PROTOCOLS (2014)
Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma
Gerald P. Linette et al.
BLOOD (2013)
SHP-1 phosphatase activity counteracts increased T cell receptor affinity
Michael Hebeisen et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Engineering improved T cell receptors using an alanine-scan guided T cell display selection system
Karolina Malecek et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2013)
Cancer Regression and Neurological Toxicity Following Anti-MAGE-A3 TCR Gene Therapy
Richard A. Morgan et al.
JOURNAL OF IMMUNOTHERAPY (2013)
Identification of a Titin-Derived HLA-A1-Presented Peptide as a Cross-Reactive Target for Engineered MAGE A3-Directed T Cells
Brian J. Cameron et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Challenges in T cell receptor gene therapy
Benjamin J. Uttenthal et al.
JOURNAL OF GENE MEDICINE (2012)
Human T cells expressing affinity-matured TCR display accelerated responses but fail to recognize low density of MHC-peptide antigen
Sharyn Thomas et al.
BLOOD (2011)
TCRs Used in Cancer Gene Therapy Cross-React with MART-1/Melan-A Tumor Antigens via Distinct Mechanisms
Oleg Y. Borbulevych et al.
JOURNAL OF IMMUNOLOGY (2011)
T Cells Targeting Carcinoembryonic Antigen Can Mediate Regression of Metastatic Colorectal Cancer but Induce Severe Transient Colitis
Maria R. Parkhurst et al.
MOLECULAR THERAPY (2011)
Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen
Laura A. Johnson et al.
BLOOD (2009)
Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases
Dirk Hockemeyer et al.
NATURE BIOTECHNOLOGY (2009)
Engineering higher affinity T cell receptors using a T cell display system
Adam S. Chervin et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2008)
Gene transfer of tumor-reactive TCR confers both high avidity and tumor reactivity to nonreactive peripheral blood mononuclear cells and tumor-infiltrating lymphocytes
Laura A. Johnson et al.
JOURNAL OF IMMUNOLOGY (2006)
Cancer regression in patients after transfer of genetically engineered lymphocytes
Richard A. Morgan et al.
SCIENCE (2006)
ScanProsite: detection of PROSITE signature matches and ProRule-associated functional and structural residues in proteins
Edouard de Castro et al.
NUCLEIC ACIDS RESEARCH (2006)
Directed evolution of human T-cell receptors with picomolar affinities by phage display
Y Li et al.
NATURE BIOTECHNOLOGY (2005)
Stable, soluble T-cell receptor molecules for crystallization and therapeutics
JM Boulter et al.
PROTEIN ENGINEERING (2003)
Monoclonal anti-MAGE-3 CTL responses in melanoma patients displaying tumor regression after vaccination with a recombinant canarypox virus
V Karanikas et al.
JOURNAL OF IMMUNOLOGY (2003)
TCRs with high affinity for foreign pMHC show self-reactivity
PD Holler et al.
NATURE IMMUNOLOGY (2003)
Exogenous peptides presented by transporter associated with antigen processing (TAP)-deficient and TAP-competent cells: Intracellular loading and kinetics of presentation
T Luft et al.
JOURNAL OF IMMUNOLOGY (2001)
Changing T cell specificity by retroviral T cell receptor display
HWHC Kessels et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
